CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin)
Ji-Hyun Park, Yong-Ho Lee, Su-Kyoung Ko, Bong-Soo Cha
Epidemiol Health. 2015;37:e2015010  Published online February 22, 2015
DOI: https://doi.org/10.4178/epih/e2015010

Excel Download

Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy
M. R. Cowie
International Journal of Clinical Practice. 2005;59(7):839-846   Crossref logo
Link1 Link2
Cost-Effectiveness of Single-Pill Combination Therapy of Amlodipine/Atorvastatin Compared with Concurrent Two-Pill Therapy in Patients with Hypertension
Y.J. Kim, S.K. Ko, C.W. Lee
Value in Health. 2014;17(7):A761   Crossref logo
Link1 Link2
CV3 DO DIFFERENCES IN DOSE IMPACT ADHERENCE TO SINGLE-PILL AMLODIPINE/ATORVASTATIN VERSUS 2-PILL AMLODIPINE AND ATORVASTATIN?
SSK Tang, BV Patel, RS Leslie, P Thiebaud, MB Nichol, HA Solomon, JB Trainer, JM Foody
Value in Health. 2007;10(6):A221-A222   Crossref logo
Link1 Link2
PCV10 COST SAVINGS OF SINGLE PILL AMLODIPINE/ATORVASTATIN THERAPY IN HYPERTENSION AND DYSLIPIDEMIA PATIENTS IN CHINA
P Dong, D Wang
Value in Health. 2010;13(7):A518   Crossref logo
Link1 Link2
PCV51 SINGLE PILL AMLODIPINE/ATORVASTATIN IS COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN KOREA
D Liew, HJ Park, S Ko
Value in Health. 2008;11(6):A396-A397   Crossref logo
Link1 Link2
Simultaneous treatment to attain blood pressure and lipid goals and reduced CV risk burden using amlodipine/atorvastatin single-pill therapy in treated hypertensive participants in a randomized controlled trial
Richard Grimm
Vascular Health and Risk Management. 2010;261   Crossref logo
Link1
PCV34 COST-EFFECTIVENESS OF ATORVASTATIN PLUS AMLODIPINE VERSUS ATORVASTATIN PLUS ATENOLOL IN HYPERTENSIVE PATIENTS WITHOUT PREVIOUS CORONARY HEART DISEASE, NORMAL TO MILDLY ELEVATED CHOLESTEROL LEVELS AND AT LEAST 3 CARDIOVASCULAR RISK FACTORS
J F Bobadilla, E Merikle, M Garcia, J Darba, C Sánchez
Value in Health. 2007;10(6):A415-A416   Crossref logo
Link1 Link2
PCV85 DOES A SINGLE PILL COMBINING AMLODIPINE AND ATORVASTATIN OFFER GREATER LONG-TERM ADHERENCE BENEFIT OVER LOW-COST GENERIC 2-PILL CALCIUM CHANNEL BLOCKER/STATIN REGIMENS?
BV Patel, SSK Tang, RS Leslie, MB Nichol, HA Solomon, JB Trainer, JM Foody
Value in Health. 2007;10(6):A432   Crossref logo
Link1 Link2
Telmisartan and Amlodipine Single-Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA-5 Study
Steen Neldam, Margreet Lang, Russell Jones,
The Journal of Clinical Hypertension. 2011;13(7):459-466   Crossref logo
Link1
Single-Pill Combination of Telmisartan/Amlodipine Versus Amlodipine Monotherapy in Diabetic Hypertensive Patients: An 8-Week Randomized, Parallel-Group, Double-Blind Trial
Arya M. Sharma, George Bakris, Joel M. Neutel, Thomas W. Littlejohn, Maureen Kobe, Naitee Ting, Ludwin Ley
Clinical Therapeutics. 2012;34(3):537-551   Crossref logo
Link1 Link2